Sharemaestro Newsreel

Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?

Elevance Health CEO Gail Boudreaux recently purchased 2,725 shares of the company's stock for approximately $1 million, increasing her total equity stake by 2%. This insider purchase is seen as a bullish signal for the company's 2026 outlook, especially in light of positive trends …

Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366

Ramiro G Peru, a director at Elevance Health (NYSE: ELV), purchased 1,000 shares of common stock at $366.05 per share on July 17, 2026. This transaction increased his direct ownership to 10,908 shares. The Form 4 filing indicates this was a direct purchase and …

Cigna Group stock trades steadily as medical benefits earnings and guidance frame valuation

Cigna Group's stock performance is analyzed through its two primary segments: medical benefits and Evernorth health services. The article highlights Evernorth's double-digit revenue growth in services like pharmacy benefit management and care management, which is crucial for offsetting more mature trends in medical benefits. …

Elevance Preparing to Exit Several Medicaid States

Elevance Health Inc., parent company of Anthem and Wellpoint, is withdrawing from the Washington D.C. Medicaid market and plans to exit other states by the end of next year. This decision is driven by a portfolio assessment focused on "long-term financial sustainability," as the …

Kaplan Fox Announces a Securities Investigation into Alignment Healthcare, Inc. (ALHC) - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP has launched a securities investigation into Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities" that "artificially inflated" the company's financial results. The complaint suggests that operating expenses were misclassified as capital expenditures, leading to …

Why Centene (CNC) Stock Is Up Today

Centene (CNC) stock rose 3.2% today, primarily driven by a broader rebound in managed-care stocks after an industry peer exceeded quarterly results and raised its 2026 outlook. Additionally, Centene secured an Illinois Medicaid contract and anticipates its Q2 2026 earnings release on July 28, …

Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares

Elevance Health CEO Gail Boudreaux reported purchasing 2,725 shares of the company's common stock on July 17, 2026, across two transactions at weighted-average prices of $366.41 and $368.25. These purchases increased her direct holdings to 171,976 shares, with an additional 60 shares held indirectly. …

Clover Health (CLOV) interim CFO sells 4,630 shares to cover taxes

Clover Health's interim CFO, Joseph Clay, sold 4,630 shares of Class A Common Stock on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a mandatory "sell-to-cover" transaction to satisfy tax withholding obligations related to the vesting of …

Clover Health CEO Andrew Toy sells $292,860 in shares

Clover Health CEO Andrew Toy sold 62,711 shares of Class A Common Stock for approximately $292,860 on July 15, 2026. This sale was non-discretionary, made to cover tax withholding obligations associated with the vesting of restricted stock units. Despite the sale, Toy still directly …

Volunteer of the Year: Diana Lenis turns empathy into action for families affected by rare disease

Diana Lenis, a registered nurse and clinical instructor at Accredo, has been named The Cigna Group's 2026 Volunteer of the Year for her extraordinary commitment to the CHARGE Syndrome Foundation. After losing two children to a rare genetic condition, Lenis dedicated her career and …

Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating

Bernstein has increased its price target for Elevance Health (ELV) to $488 from $482, while reiterating an Outperform rating on the stock. This adjustment suggests a positive outlook on the company's future performance.

Centene stock holds near health insurance peers after latest earnings

Centene Corp. (US15133V1035) remains a key managed-care company, with its latest Q1 2026 earnings revealing $41.4 billion in premium and service revenue, $2.90 adjusted diluted EPS, and 28.3 million members. These figures provide a strong fundamental baseline for its stock, primarily driven by government-sponsored …

UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth

UnitedHealth Group's Q2 2026 earnings call emphasized an operational reset, with strong Medicare performance and Optum's execution balancing commercial insurance pressures. The company raised its 2026 adjusted EPS outlook, focusing on building a stable earnings base for 2027 and beyond, despite ongoing challenges in …

CSW Industrials, Inc. Declares Quarterly Dividend, Payable on August 14, 2026

CSW Industrials, Inc. has announced a regular quarterly cash dividend of $0.30 per share. This dividend is scheduled to be paid on August 14, 2026, to shareholders who are on record as of the close of business on July 31, 2026.

RBC Raises Price Target on Quaker Houghton to $177 From $157, Keeps Outperform Rating

RBC Capital Markets has increased its price target for Quaker Houghton (NYSE: KWR) to $177 from $157, while maintaining an Outperform rating on the stock. This adjustment reflects continued analyst confidence in the industrial process fluids provider. The report was issued on July 17, …

Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating

Leerink Partners adjusted its price target on Elevance Health (NYSE: ELV) to $395, up from $364, while reaffirming a Market Perform rating on the stock. This revision reflects the analyst's updated valuation for the healthcare company.

UnitedHealth: Huge Q2 Beat Proves Turnaround Is In Full Force (NYSE:UNH)

UnitedHealth Group Incorporated (UNH) reported strong Q2 results, significantly beating analyst consensus and proving its turnaround strategy is effective. The company is prioritizing margin restoration over customer growth, leading to improved operating discipline and a deliberate reduction in insured patients. Management raised 2026 guidance, …

UnitedHealth Stock: The 1 Number in the Earnings Beat That Has Shares Jumping

UnitedHealth Group's stock surged after the healthcare giant surpassed second-quarter earnings expectations and raised its guidance. The primary driver of this impressive performance was the company's medical-cost ratio, which played a significant role in lifting healthcare stocks.

UnitedHealth Group Incorporated Stock 12‑Month Price Target Raised to $471.8, Implies 11% Upside

UnitedHealth Group Incorporated's average 12-month price target has been increased to $471.8 by 25 analysts, up from $467.88, indicating a potential 11% upside from the July 16 closing price. The consensus rating for UNH remains "Buy" among 30 analysts, with 22 recommending Buy, 7 …

Arkansas Explained: What’s happening to the state’s Medicaid expansion?

Arkansas's Medicaid expansion program, ARHOME, faces challenges as one of its main insurance providers, Centene Corp., is withdrawing in 2027 due to funding issues. The state, a pioneer in hybrid expansion models and work requirements, is also preparing for new federal mandates that will …

Molina Healthcare, Construction Partners set for S&P index changes

Molina Healthcare and Construction Partners are slated for changes in S&P indexes, with Molina Healthcare moving from the S&P MidCap 400 to the S&P 500, and Construction Partners transferring from the S&P SmallCap 600 to the S&P MidCap 400. These adjustments are a result …

UnitedHealth Results Handily Beat Wall Street Expectations

UnitedHealth Group reported better-than-expected earnings, leading the healthcare company to significantly raise its full-year earnings projection. This news boosted investor confidence, with UnitedHealth shares rising 6% in premarket trading. The results align with the company's promised financial turnaround.

Will Declining Membership Affect Molina Healthcare's Q2 Earnings?

Molina Healthcare stock trades steadily as Medicaid growth supports earnings

Molina Healthcare (MOH) stock is trading steadily, supported by consistent Medicaid-focused growth, as evidenced by double-digit revenue expansion and strong membership trends across government programs. The company generated approximately $36 billion in revenue in 2025, driven by increased Medicaid and Affordable Care Act marketplace …

Progyny COO Melissa B. Cummings disposes of common shares worth $109,393.58

Progyny COO Melissa B. Cummings reduced her common stock holdings by disposing of 3,437 shares in transactions totaling $109,393.58 on July 14, 2026. This included selling 2,244 shares under a Rule 10b5-1 plan and withholding 1,193 shares for tax obligations related to restricted stock …

CVS Health (CVS) Stock Looks Pricey On FTC Insulin Settlement

CVS Health's stock has seen a significant increase over the past year, returning 74.4%. However, its current valuation, with a P/E ratio of 46.3x, is considered expensive compared to the Healthcare industry average of 25.5x and a fair P/E of 40.7x. The article suggests …

Despite earnings celebration, UnitedHealth signals more financial pain for employers

UnitedHealth Group exceeded Q2 earnings expectations, boosting its stock. However, statements from their earnings call suggest impending financial difficulties for American businesses and workers due to rising health insurance premiums. The article highlights that medical costs for UnitedHealthcare's employer clients increased by 11%.

Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says

A strong second quarter by Elevance Health has led Truist to increase its estimates for the company's performance in 2026 and 2027. This positive revision by Truist reflects confidence in Elevance Health's financial outlook following the robust Q2 results.

Elevance Health earnings call: growth levers amid strain

Elevance Health's Q2 earnings call highlighted growth levers despite Medicaid and high-cost service pressures, with management expressing confidence in returning to double-digit EPS growth by 2027. The company beat earnings expectations, raised its 2026 EPS guidance, and outlined strategies including improving Medicare Advantage economics, …

UnitedHealth Group Q2 Earnings Call Highlights

UnitedHealth Group reported significantly higher second-quarter 2026 earnings, raising its full-year outlook despite elevated commercial medical costs. The company's adjusted EPS rose to $6.38, and total revenue reached $112 billion, with operating earnings up 55%. While Medicare Advantage performance improved, commercial margins are expected …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Molina Healthcare, Inc. (MOH) and certain officers/directors. The firm encourages shareholders who purchased Molina securities before February 5, 2025, and still hold them, to contact them to assist with the …

Clover Health: Counterpart Health CEO Wai sells $113,084 in stock.

Conrad Wai, CEO of Counterpart Health at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 24,215 shares of the company’s Class A Common Stock for $113,084. This sale was a "sell to cover" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock …

Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600

Molina Healthcare Inc. (NYSE: MOH) is set to replace National Storage Affiliates Trust (NYSE: NSA) in the S&P MidCap 400, while Construction Partners Inc. (NASD: ROAD) will join the S&P SmallCap 600, replacing Molina Healthcare. These changes will be effective prior to the opening …

UnitedHealth raises 2026 guidance again as cost controls pay off in Q2

UnitedHealth reported a significant profit increase of 62% to $5.5 billion in Q2 2026, driven by improved earnings in its insurance and value-based care businesses. The company raised its adjusted earnings per share outlook for 2026 to $19.50-$20, exceeding analyst expectations, as cost control …

Elevance Health Inc. stock underperforms Thursday when compared to competitors

Elevance Health Inc. (ELV) stock declined by 4.48% on Thursday, closing at $372.85, amidst a general downturn in the stock market where the S&P 500 Index and Dow Jones Industrial Average also fell. This marks the second consecutive day of losses for Elevance Health …

Clover Health (CLOV) CEO sells 62,711 shares for RSU tax withholding

Clover Health Investments CEO Andrew Toy sold 62,711 Class A shares at a weighted average price of $4.67 per share. This mandatory "sell to cover" transaction was executed to fulfill tax withholding obligations tied to the vesting of 6.25% of his restricted stock units …